Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLTE Belite Bio, Inc.

休市中 10-04 16:00:00 EDT

50.99

+0.09

+0.18%

盘后50.99

+0.000.00%

16:00 EDT

最高51.15	最低50.49	成交量5.02万
今开50.98	昨收50.90	日振幅1.30%
总市值15.61亿	流通市值6.46亿	总股本3,061万
成交额255.43万	换手率0.40%	流通股本1,267万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":50.99,"timestamp":1728072000000,"preClose":50.9,"halted":0,"volume":50201,"hourTrading":{"tag":"盘后","latestPrice":50.99,"preClose":50.99,"latestTime":"16:00 EDT","volume":12,"amount":608.16,"timestamp":1728072001094},"delay":0,"floatShares":12673158,"shares":30612359,"eps":-1.220325,"marketStatus":"休市中","marketStatusCode":7,"change":0.09,"latestTime":"10-04 16:00:00 EDT","open":50.98,"high":51.15,"low":50.49,"amount":2554293.747732,"amplitude":0.012967,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.220325,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1728288000000},"adr":0,"listingDate":1651204800000,"adjPreClose":50.9,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":50.99,"preClose":50.99,"latestTime":"16:00 EDT","volume":12,"amount":608.16,"timestamp":1728072001094},"volumeRatio":1.650198},"requestUrl":"/m/hq/s/BLTE","defaultTab":"news","newsList":[{"id":"2470595837","title":"Belite Bio Inc盘中异动 临近午盘快速下挫5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470595837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470595837?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:38","pubTimestamp":1727365084,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日23时38分，Belite Bio Inc股票出现波动，股价大幅跳水5.96%。截至发稿，该股报43.70美元/股，成交量2.6015万股，换手率0.08%，振幅5.10%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.45%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262338049719cdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262338049719cdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007","BK4139","KTTA"],"gpt_icon":0},{"id":"2464236480","title":"Belite Bio 宣布委任医学博士Hendrik P. N. Scholl 为首席医疗总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2464236480","media":"GlobeNewswire","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464236480?lang=zh_cn&edition=full","pubTime":"2024-09-04 08:16","pubTimestamp":1725408960,"startTime":"0","endTime":"0","summary":"今天该公司宣布，其董事会已委任医学博士 Hendrik P. N. Scholl 为首席医疗总监，即时生效。目前Hendrik Scholl博士拥有匈牙利布达佩斯塞梅尔维斯大学的荣誉博士学位，并担任奥地利维也纳医学大学的客座教授。Hendrik Scholl 毕业于德国图宾根大学医学院，取得文学硕士学位及医学博士学位。关于 Belite Bio Belite Bio 是一家临床阶段生物制药和药物开发公司，致力于针对尚无有效治疗方法的视网膜退化病变开发新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/04/2940166/0/zh-hant/Belite-Bio-%E5%AE%A3%E4%BD%88%E5%A7%94%E4%BB%BB%E9%86%AB%E5%AD%B8%E5%8D%9A%E5%A3%ABHendrik-P-N-Scholl-%E7%82%BA%E9%A6%96%E5%B8%AD%E9%86%AB%E7%99%82%E7%B8%BD%E7%9B%A3.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0127658192.USD","BK4141","BK4575","BK4573","LU0056508442.USD","LU2360106780.USD","LU2458330169.SGD","LU1852331112.SGD","BK4554","IE00B5949003.HKD","LU1880398554.USD","LU0823434740.USD","LU2098885051.SGD","LU1064131342.USD","BLTE","LU0823421416.USD","LU0198837287.USD","LU2264538146.SGD","BK4588","BK4566","LU1303367103.USD","BK4534","LU0082616367.USD","LU1951198990.SGD","IE0004445239.USD","LU1316542783.SGD","IE0009356076.USD","BK4532","BK4512","LU1951200564.SGD","BK4007","LU0109392836.USD","LU1923623000.USD","LU0889565833.HKD","LU2458330243.SGD","LU0823434583.USD","LU0642271901.SGD","LU0081259029.USD","BK4529","LU1803068979.SGD","LU0719512351.SGD","LU1988902786.USD","LU0823421333.USD","LU1242518857.USD","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","LU2250418816.HKD","LU0979878070.USD","LU1989764664.SGD"],"gpt_icon":1},{"id":"2458329722","title":"Belite Bio Inc盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458329722","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458329722?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:50","pubTimestamp":1723146650,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时50分，Belite Bio Inc股票出现波动，股价大幅上涨5.03%。截至发稿，该股报49.10美元/股，成交量1.1041万股，换手率0.04%，振幅4.86%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为3.64%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035050968253d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035050968253d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2457977813","title":"Belite Bio Inc盘中异动 股价大跌5.42%报45.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977813","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977813?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864724,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Belite Bio Inc股票出现异动，股价快速下挫5.42%。截至发稿，该股报45.05美元/股，成交量1132股，换手率0.00%，振幅0.00%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为1.36%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213205af95f9fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213205af95f9fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2445176386","title":"Belite Bio Inc盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445176386","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445176386?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:56","pubTimestamp":1718978214,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时56分，Belite Bio Inc股票出现波动，股价快速下挫5.44%。截至发稿，该股报46.26美元/股，成交量1.8156万股，换手率0.06%，振幅3.80%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.60%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621215654941f022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621215654941f022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2435513486","title":"坎托菲茨杰拉德公司：重申Belite Bio(BLTE.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435513486","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435513486?lang=zh_cn&edition=full","pubTime":"2024-05-15 22:56","pubTimestamp":1715785005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2432136491","title":"Belite Bio Inc盘中异动 大幅上涨5.11%报43.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432136491","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432136491?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:59","pubTimestamp":1714766357,"startTime":"0","endTime":"0","summary":"北京时间2024年05月04日03时59分，Belite Bio Inc股票出现异动，股价急速拉升5.11%。截至发稿，该股报43.20美元/股，成交量5.4684万股，换手率0.18%，振幅5.45%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.70%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040359177925c400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040359177925c400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2430780429","title":"Belite Bio Inc盘中异动 股价大涨5.18%报39.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430780429","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430780429?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:51","pubTimestamp":1714157486,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日02时51分，Belite Bio Inc股票出现波动，股价急速上涨5.18%。截至发稿，该股报39.97美元/股，成交量2.9147万股，换手率0.10%，振幅4.95%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.37%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270251277a565622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270251277a565622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2429127301","title":"Belite Bio Inc盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429127301","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429127301?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:08","pubTimestamp":1713888491,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日00时08分，Belite Bio Inc股票出现异动，股价快速上涨5.79%。截至发稿，该股报36.48美元/股，成交量9508股，换手率0.03%，振幅6.24%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.36%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240008117922b607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240008117922b607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2428543072","title":"Belite Bio Inc盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428543072","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428543072?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:25","pubTimestamp":1713464756,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时25分，Belite Bio Inc股票出现异动，股价快速拉升5.17%。截至发稿，该股报34.00美元/股，成交量8722股，换手率0.03%，振幅3.93%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.58%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190225577a53d1a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190225577a53d1a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2428323111","title":"Belite Bio Inc盘中异动 临近午盘大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428323111","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428323111?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:59","pubTimestamp":1713369567,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时59分，Belite Bio Inc股票出现波动，股价快速下跌5.03%。截至发稿，该股报34.08美元/股，成交量5031股，换手率0.02%，振幅2.88%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.59%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417235928861e6c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417235928861e6c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2428804495","title":"Belite Bio Inc盘中异动 大幅跳水5.71%报34.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428804495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428804495?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:13","pubTimestamp":1713294788,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时13分，Belite Bio Inc股票出现异动，股价快速跳水5.71%。截至发稿，该股报34.51美元/股，成交量1.8054万股，换手率0.06%，振幅4.26%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.40%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703130887e81070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703130887e81070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2426527731","title":"Belite Bio Inc盘中异动 股价大跌5.24%报37.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426527731","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426527731?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:21","pubTimestamp":1712935300,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日23时21分，Belite Bio Inc股票出现波动，股价快速跳水5.24%。截至发稿，该股报37.81美元/股，成交量6956股，换手率0.02%，振幅2.56%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.92%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122321417a527963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122321417a527963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2425349927","title":"Belite Bio Inc盘中异动 下午盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425349927","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425349927?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:18","pubTimestamp":1712254698,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日02时18分，Belite Bio Inc股票出现异动，股价急速下挫5.38%。截至发稿，该股报38.16美元/股，成交量8301股，换手率0.03%，振幅4.66%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.44%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405021819861e372f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405021819861e372f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CADL","BK4007","BLTE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.belitebio.com","stockEarnings":[{"period":"1week","weight":0.0954},{"period":"1month","weight":0.0533},{"period":"3month","weight":0.1207},{"period":"6month","weight":0.287},{"period":"1year","weight":0.6946},{"period":"ytd","weight":0.1145}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.04},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.1052},{"period":"1year","weight":0.3498},{"period":"ytd","weight":0.2055}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Belite Bio, Inc于2018年3月27日在开曼群岛注册成立。该公司是一家临床阶段的生物制药及药物开发公司，专注于针对目前无法治疗的眼部疾病的新疗法，这些疾病涉及有重大未满足医疗需求的视网膜变性，例如（i）萎缩性年龄相关性黄斑变性（AMD），通常称为地理萎缩（GA），或晚期干性AMD，和（ii）常染色体隐性遗传Stargardt病1型，或STGD1，这两种疾病都会导致进行性视力丧失，导致永久性失明。该公司的药物研发管道还包括一种小分子口服复方药物，用于治疗代谢性疾病，如非酒精性脂肪肝、非酒精性脂肪性肝炎、NASH、2型糖尿病、T2D和痛风。","exchange":"NASDAQ","name":"Belite Bio, Inc.","nameEN":"Belite Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Belite Bio, Inc.,BLTE,Belite Bio, Inc.股票,Belite Bio, Inc.股票老虎,Belite Bio, Inc.股票老虎国际,Belite Bio, Inc.行情,Belite Bio, Inc.股票行情,Belite Bio, Inc.股价,Belite Bio, Inc.股市,Belite Bio, Inc.股票价格,Belite Bio, Inc.股票交易,Belite Bio, Inc.股票购买,Belite Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}